Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response

Anthony Z. Wang(Washington University in St. Louis), Jay A. Bowman-Kirigin(Washington University in St. Louis), Rupen Desai(Washington University in St. Louis), Liang‐I Kang(Washington University in St. Louis), Pujan R. Patel(Washington University in St. Louis), Bhuvic Patel(Washington University in St. Louis), Saad M. Khan(Washington University in St. Louis), Diane Bender(Washington University in St. Louis), M. Caleb Marlin(Oklahoma Medical Research Foundation), Jingxian Liu(James S. McDonnell Foundation), Joshua W. Osbun(Washington University in St. Louis), Eric C. Leuthardt(Washington University in St. Louis), Michael R. Chicoine(Washington University in St. Louis), Ralph G. Dacey(Washington University in St. Louis), Gregory J. Zipfel(Washington University in St. Louis), Albert H. Kim(Washington University in St. Louis), David G. DeNardo(Molecular Oncology (United States)), Allegra A. Petti(Washington University in St. Louis), Gavin P. Dunn(Massachusetts General Hospital)
Genome Medicine
May 9, 2022
Cited by 110Open Access
Full Text

Abstract

BACKGROUND: Recent investigations of the meninges have highlighted the importance of the dura layer in central nervous system immune surveillance beyond a purely structural role. However, our understanding of the meninges largely stems from the use of pre-clinical models rather than human samples. METHODS: Single-cell RNA sequencing of seven non-tumor-associated human dura samples and six primary meningioma tumor samples (4 matched and 2 non-matched) was performed. Cell type identities, gene expression profiles, and T cell receptor expression were analyzed. Copy number variant (CNV) analysis was performed to identify putative tumor cells and analyze intratumoral CNV heterogeneity. Immunohistochemistry and imaging mass cytometry was performed on selected samples to validate protein expression and reveal spatial localization of select protein markers. RESULTS: In this study, we use single-cell RNA sequencing to perform the first characterization of both non-tumor-associated human dura and primary meningioma samples. First, we reveal a complex immune microenvironment in human dura that is transcriptionally distinct from that of meningioma. In addition, we characterize a functionally diverse and heterogenous landscape of non-immune cells including endothelial cells and fibroblasts. Through imaging mass cytometry, we highlight the spatial relationship among immune cell types and vasculature in non-tumor-associated dura. Utilizing T cell receptor sequencing, we show significant TCR overlap between matched dura and meningioma samples. Finally, we report copy number variant heterogeneity within our meningioma samples. CONCLUSIONS: Our comprehensive investigation of both the immune and non-immune cellular landscapes of human dura and meningioma at single-cell resolution builds upon previously published data in murine models and provides new insight into previously uncharacterized roles of human dura.


Related Papers